HRTX

HERON THERAPEUTICS INC

HRTX·427746102·US·Common Stock·Healthcare - Biotechnology-Activist

HRTX (HERON THERAPEUTICS INC) is held by 86 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($8.1M), VANGUARD CAPITAL MANAGEMENT LLC ($6.2M), MILLENNIUM MANAGEMENT LLC ($6.1M). Net institutional sentiment: Mixed.

86
Holders
Avg rating(25 Elite)
$46.5M
Total Value
52% (96)
Fund Consensus
46 buying - 42 selling
HRTXSmart Money Verdict
View all
Held by 86 funds
25 elite
Who's Trading
ActivistADAdage Capital Management, L.P.0.0%May 13, 2026
InsiderHEHensley Mark EarlExercise 125K shMay 6, 2026
InsiderCACollard Craig AExercise 50K shApr 30, 2026
InsiderCACollard Craig AExercise 35K shApr 30, 2026
InsiderDIDuarte IraExercise 14K shApr 30, 2026
InsiderDIDuarte IraExercise 12K shApr 30, 2026
InsiderFPForbes William PExercise 12K shApr 30, 2026
InsiderFPForbes William PExercise 12K shApr 30, 2026
InsiderHEHensley Mark EarlExercise 12K shApr 30, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
10.1M(-1.1%)$8.1M0.0%-74.38%
0
New
7.8M$6.2M0.0%-64.35%
38
Increased
7.6M(+6.4%)$6.1M0.0%-70.03%
29
Decreased
4M(-1.7%)$3.2M0.0%-95.50%
0
Increased
3.8M(+1.7%)$3.1M0.0%-83.53%
27
Decreased
2.6M(-13.4%)$2.1M0.0%-87.74%
0
Unchanged
2.6M$2.1M0.0%-92.91%
0
Increased
2.3M(+9.3%)$1.8M0.0%-80.08%
28
Decreased
1.7M(-10.3%)$1.4M0.0%-80.05%
0
Decreased
1.4M(-2.8%)$1.1M0.0%-95.87%
0
New
1.3M$1M0.0%-64.35%
35
Increased
1.2M(+7.4%)$938,1370.0%-97.19%
27
New
1.2M$922,1710.0%-64.35%
35
Increased
1.1M(+6.8%)$845,6610.0%-75.06%
27
Increased
962,505(+118.6%)$770,1000.0%-66.98%
40
Increased
859,958(+26.9%)$688,0520.0%-69.59%
30
Decreased
759,269(-63.8%)$607,4910.0%-79.56%
0
Increased
641,587(+70.5%)$513,3340.0%-67.03%
36
Increased
526,293(+51.6%)$421,0870.0%-78.13%
33
Decreased
513,413(-46.7%)$410,7810.0%-81.38%
0

Showing 1-20 of 96

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used